News Article | May 8, 2017
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Notices of Allowance has been issued for patents covering key technological features of the Company’s Quell® Wearable Pain Relief Technology™ by the European Patent Office, the Japan Patent Office, and the State Intellectual Property Office of the People's Republic of China. The allowed patent claims address an essential element in the Company’s proprietary technology that automatically controls nerve stimulation to optimize pain relief. In particular, the patent covers a novel calibration procedure that customizes nerve stimulation for each Quell user. In addition, the allowed patent claims protect the unique integrated Quell design that combines a neurostimulator, an electrode array, and an accelerometer. This technology enables automatic adjustment of nerve stimulation based on the user’s position and movement, with applications such as optimizing therapy during sleep. The Company expects the three patents to formally issue by the third quarter of 2017. “We are pleased to have received these important Notice of Allowances for the Quell technology in the European Union, Japan and China. These are the three key expansion markets for the Quell business,” said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. "We are currently in discussions with strategic partners about licensing or distributing Quell outside our core North American market. These patent claim allowances may help advance these discussions towards formal agreements.” About Quell Quell is designed for millions of people suffering from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell users can personalize and manage therapy discreetly via the Quell Relief app. Quell also offers advanced health tracking relevant to chronic pain sufferers including pain, sleep, activity, and gait. Quell was the winner of the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. Quell is available at select healthcare professionals and retailers. Visit QuellRelief.com for more information. About NeuroMetrix NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform that helps patients optimize their therapy and decrease the impact of chronic pain on their quality of life. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com.
News Article | October 13, 2016
ST. LOUIS, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that the State Intellectual Property Office of the People’s Republic of China has awarded a patent protecting the Company’s Vdrive® robotic navigation system with V-Loop™ variable loop catheter manipulator. The patent is the second awarded to Stereotaxis in China for its Vdrive system and related disposable devices. The first patent covered the Company’s V-CAS™ and V-CAS Deflect™ catheter advancement systems, and its V-Sono™ ICE catheter manipulator, as well as all device interfaces and methods. “We continue to generate strong growth in the Asia Pacific market, which improved procedure volume by 65% in the first half of 2016 over the same period last year and now comprises nearly 10% of our worldwide procedures,” said William C. Mills, Stereotaxis Chief Executive Officer. “The market in China represents significant potential for our remote, robotic technologies and this patent reflects the further expansion of our proprietary technology designed to achieve greater safety, single operator efficiencies and improved patient outcomes in cardiac ablations.” Employed in conjunction with the Stereotaxis Niobe® ES magnetic navigation system, the V-Loop system remotely controls the advancement, retraction, rotation, tip deflection and loop size of a compatible circular mapping catheter, which is used in over 60,000 complex ablation procedures worldwide each year. Its unique design enables a single operator to remotely control both the ablation catheter and circular mapping catheter and to do so with greater stability and maneuverability of the circular mapping catheter, supporting improved procedure results. About Stereotaxis Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch® Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive® robotic navigation system and consumables. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono™ ICE catheter manipulator, V-Loop™ variable loop catheter manipulator, and V-CAS™ catheter advancement system have received clearance in the United States, Canada, and the European Union. The V-CAS Deflect™ catheter advancement system has been CE Marked for sale in the European Union. For more information, please visit www.stereotaxis.com. This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness, or to obtain additional financing, in either case on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from healthcare reform in the United States, including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that the Company will recognize revenue related to its purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of the Company's control. In addition, these orders and commitments may be revised, modified, delayed or canceled, either by their express terms, as a result of negotiations, or by overall project changes or delays.
News Article | November 8, 2016
Business of Intellectual Property Asia Forum to Open Next Month Concurrent Fairs to Analyse Opportunities and Challenges for SMEs To explore intellectual property-related business, the sixth Business of Intellectual Property Asia (BIP Asia) Forum will be held at the Hong Kong Convention and Exhibition Centre (HKCEC) on 1-2 December. Three other SME-oriented fairs: InnoDesignTech Expo, World SME Expo and the Hong Kong International Franchising Show, will be held concurrently from 1 to 3 December at the HKCEC to help SMEs grasp business opportunities. Raymond Yip, Deputy Executive Director, HKTDC, said the four events cover areas including design, technology, entrepreneurship, operation management, brand promotion and intellectual property. He said that the combined impact of the fairs provides SMEs with a highly effective one-stop value-adding platform for enhancing their competitiveness and all-round development. IP in the innovation era Organised by the Hong Kong Special Administrative Region (HKSAR) Government, the HKTDC and the Hong Kong Design Centre, this year's BIP Asia Forum adopts the theme of "IP in the Innovation Era". The event is expected to attract more than 2,400 IP professionals and industry leaders. CY Leung, Chief Executive of the HKSAR, will be joined by Wang Binying, Deputy Director General, World Intellectual Property Organization, Yi Xiaozhun, Deputy Director General, World Trade Organization and Deng Yingjun, Deputy Director General, Office of General Affairs of Patent Office, State Intellectual Property Office of the People's Republic of China, at the opening session. During the forum, more than 80 guest speakers will share their expertise and experiences from various IP perspectives. BIP Asia will comprise three plenary sessions, with two happening on the first day. The first, "Growth and Opportunities: The Next IP Development in Asia", features IP leaders Dr Song Liuping, Senior Vice President and Chief Legal Officer, Huawei Technologies Co, Ltd; and Dr Uwe Over, Corporate Vice President, Head of IP and Associate General Counsel, Henkel AG & Co KGaA. The second plenary session, "The Future is Open: Managing and Commercialising IP Assets", will bring together Roger Martin, Senior Vice President and Chief IP Strategist, Qualcomm Incorporated; Kenneth S Korea, Senior Vice President and Head of US IP Center, Samsung Electronics Co, Ltd; and Dr Udo Meyer, DE, Senior Vice President and Head of Global Intellectual Property, BASF SE to share their views on the trends on open innovation. On the second day of the forum, the plenary session "Looking into China's 13th Five-Year Plan: New Opportunities in the Innovation Era" will welcome Yang Guoxin, Deputy Division Director, Planning and Statistics Division of Planning and Development Department, State Intellectual Property Office of the People's Republic of China; Wang Yueping, Deputy Managing Director, Energy Service Division, CGN CLP Energy Services (Shenzhen) Co, Ltd; and Dr Raymond Leung, Founder and Chairman of Altai Technologies Ltd and Founding Chairman and Strategy Advisor of Amperex Technology Ltd (ATL) to analyse the IP opportunities arising from China's 13th Five-Year Plan. Technological innovation is closely linked to intellectual property. The debut Global Tech Summit will be held on the opening day of BIP Asia, where representatives from research institutes and technology enterprises, such as cherrypicks, Siemens, Hanson Robotics, Vitargent and VeriFi (Hong Kong), will explore global technology trends and share success cases of technology breakthroughs. More than 15 breakout sessions will be organised covering four broad areas: IP Practical Tips, IP Market Insight, Industry-specific IP and Quick Guide to IP Basics. Hot-button issues such as IP portfolio management, IP financing, Brexit and start-up IPs will be discussed. At the exhibition area of the forum, more than 80 exhibitors, including the World Intellectual Property Organization as well as large international technology corporations, top-tier research centres and universities and IP service providers, such as Marks & Clerk, China Patent Agent and Deacons, will provide on-site consulting services. "Urbanovation" at InnoDesignTech Expo The 12th InnoDesignTech Expo will include the Trade Hall and Inspiration Hall, gathering a record of around 450 exhibitors from 22 countries and regions. Under the theme "Urbanovation", the Inspiration Hall will explore how design and innovation becomes a key driving force to urban lifestyle and development. Under the categories of smart architecture, smart infrastructure, smart mobility and smart lifestyle, exhibits and interactive games will showcase how creative solutions can solve social problems. Featured displays include the new-generation aluminium mobile home "ALPOD", curated by James Law Cybertecture, Tesla Model X electric car and the innovative home design of "Checkered Playroom Oasis" as well as service robots, 3D food printing, AR and VR experiences. Chicago, this year's partner city of the InnoDesignTech Expo, will bring its unique design style to the event under the theme "Chicago Made". A number of regions with strong design and innovation including Victoria (Australia), Hessen (Germany), Bali (Indonesia), Chungnam (Korea) and Southern Sweden will also bring local innovative designs, products and commercial solutions to the expo. Create Hong Kong (CreateHK) of the Government of the Hong Kong Special Administrative Region* is once again sponsoring the "Hong Kong Creative Force" in the Inspiration Hall. The zone showcases a series of outstanding local creations, including those from cross-discipline collaborative projects "Love Seat", "Urban Playroom", "Urban Oasis", and successful cases of brand upgrading and new media promotions. The Hong Kong Maker Club will also join the expo again to present the fruits of Hong Kong makers such as Sophie IV solar-powered car and robot boxing league. The Trade Hall will feature a number of thematic zones where one-stop commercial solutions using innovative designs and technology will be showcased. A number of leading Hong Kong creative media companies will demonstrate the latest technology at the all-new "AR & VR Zone". An AR & VR experience area will enable visitors to try the technology first-hand and learn how it can be applied across different sectors. On-site demonstrations at the "3D Printing Solutions Zone" will include the printing of precious metals, food and prosthetics. The "Global Innovation Zone" will feature more than 100 inventors showcasing innovations from different sectors. About 70 local start-up companies will gather at the "Creative and Tech Start-up Zone" to connect with potential business partners and investors. And the Retro Spot is where entrepreneurs will be able to "Get in the Ring" to pitch their creative ideas and commercial applications to judges and the audience. During the fair, 15 thematic seminars and workshops will be held under the thematic tracks of "Creativity for Business", "Innovation for Business" and "Start-up Ventures". Major topics include "How Creativity Empowers Brand Management?", "Global Design Trends", "Immersive Marketing with Virtual Reality", "Smart Data and Innovative Marketing" and "Dialogue with Creative Minds". Everything small businesses need at World SME Expo The 16th World SME Expo provides small- and medium-sized enterprises with a wide range of business solutions and supporting services, helping SMEs explore new opportunities. This year, the Opportunities Hall will feature a dedicated "Belt and Road Zone", where more than 40 exhibitors from 13 Belt and Road countries including India, Vietnam, Thailand and Malaysia will showcase the latest developments and partnership opportunities in their respective countries. The Hong Kong Chinese Enterprises Association will introduce economic and trade cooperation zones and industrial parks in Malaysia, Laos, Egypt and Belarus that have been set up using mainland investment. It will also explore the local investment market and analyse investment conditions in different markets. The Solutions Hall will continue to provide SMEs with a range of practical business solutions including e-tailing services, IT services as well as government, institutional and operational support. The seminar series continues to be a highlight of the World SME Expo. More than 30 seminars and workshops will be held this year, including "Innovation & Branding - The New Breed of SMEs", organised by the HKTDC and the Trade and Industry Department, where new leading SMEs will discuss ways to develop products and services, adjust business operation models and forge a successful brand transformation. The series "Embracing The Latest Trend of E-Commerce" will welcome industry experts from Google, LinkedIn and Baidu to introduce mobile apps, social media trends and digital marketing strategies. Renowned entrepreneurs at the event will include Quincy Wong, Chairman, Convoy Global Holdings Ltd, who will discuss ways to lift business performance through innovative ideas; Vincent Tsui, Chief Marketing Officer, Next Digital Ltd, will share promotional strategies for SMEs and artist Skye Chan will share her experience of opening an e-tailing shop. Business matching services and networking events will be arranged to help visitors explore more business opportunities. Expanding business with franchising Following its successful launch last year, the Hong Kong International Franchising Show returns to provide a one-stop platform for companies and entrepreneurs to look for franchising brands, find business partners and pick up top franchising tips. The show will feature more than 100 exhibitors from around the world bringing such brands as American pizza chain Papa John's Pizza, Trendyland Studio, which specialises in selling Disney products and providing Disney-themed photography services, as well as the local food and beverage brand KamCha. New exhibiting brands include the Canadian specialty coffee brand Cafe Cafe, the football training system Coerver Coaching, international courier intermediary company InXpress and Hong Kong's School of Creativity. The show offers numerous franchising opportunities in different sectors with "Catering", "Non-Catering" and "International" zones to help companies match with partners and expand their business. A new seminar series "Advice from the Wise" will debut this year, featuring industry experts from the United States, Japan, Korea, Australia and the Chinese mainland to share tips for entering the mainland market, new operating ideas for the catering sector and how to develop domestic services (such as supervisory care, football training, courier service and laundry) into franchises. The "Round Table Meeting" will analyse the latest franchising trends in Asia-Pacific region, including Singapore, Australia, Korea, Indonesia, the Philippines, Taiwan, the mainland and Hong Kong. BIP Asia Forum, InnoDesignTech Expo, World SME Expo and the Hong Kong International Franchising Show are events of the Innovation and Intellectual Property Week. InnoDesignTech Expo, World SME Expo and Hong Kong International Franchising Show are open to industry players and the public with free admission. Photo Download: http://bit.ly/2fjcr75 Media Registration: Media may register on-site with their business cards and/or media identification. To view press releases in Chinese, please visit http://mediaroom.hktdc.com/tc. * Disclaimer: Create Hong Kong of the Government of the Hong Kong Special Administrative Region provides funding support to the project only, and does not otherwise take part in the project. Any opinions, findings, conclusions or recommendations expressed in these materials/events (or by members of the project team) are those of the project organizers only and do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Communications and Creative Industries Branch of the Commerce and Economic Development Bureau, Create Hong Kong, the CreateSmart Initiative Secretariat or the CreateSmart Initiative Vetting Committee. About HKTDC Established in 1966, the Hong Kong Trade Development Council (HKTDC) is a statutory body dedicated to creating opportunities for Hong Kong's businesses. With more than 40 offices globally, including 13 on the Chinese mainland, the HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. With 50 years of experience, the HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing information via trade publications, research reports and digital channels including the media room. For more information, please visit: www.hktdc.com/aboutus. Follow us on Google+, Twitter @hktdc, LinkedIn. Google+: https://plus.google.com/+hktdc Twitter: http://www.twitter.com/hktdc LinkedIn: http://www.linkedin.com/company/hong-kong-trade-development-council Contact:
News Article | December 1, 2016
The sixth Business of Intellectual Property Asia (BIP Asia) Forum opened today and continues through tomorrow at the Hong Kong Convention and Exhibition Centre (HKCEC). Jointly organised by the Hong Kong Special Administrative Region (HKSAR) Government, the Hong Kong Trade Development Council (HKTDC) and the Hong Kong Design Centre (HKDC), this year's BIP Asia Forum adopts the theme of "IP in the Innovation Era". The event features more than 80 prominent speakers and is expected to attract more than 2,400 IP professionals. At the opening ceremony, CY Leung, Chief Executive of the HKSAR, was joined by Wang Binying, Deputy Director General, World Intellectual Property Organization, Yi Xiaozhun, Deputy Director General, World Trade Organization and Deng Yingjun, Deputy Director General, Office of General Affairs of Patent Office, State Intellectual Property Office of the People's Republic of China. "In a fast-changing world driven by innovation and technology, IP is an increasingly important currency for companies around the globe," Margaret Fong, Executive Director, HKTDC, said. "To shed more light on the key trends, the BIP Asia Forum gathers leading players from all sides of the IP equation: the policymakers who shape the regulatory environment, the innovators who are pushing the boundaries of technology and the brand leaders that have been able to convert great ideas into high-demand products and services." Forecasting IP trends in Asia The opening day featured two plenary sessions. The plenary entitled "Growth and Opportunities: The Next IP Development in Asia" heard Dr Song Liuping, Senior Vice President and Chief Legal Officer, Huawei Technologies Co., Ltd. and Dr Uwe Over, Corporate Vice President, Head of IP and Associate General Counsel, Henkel AG & Co. KGaA analyse upcoming IP trends in Asia in the innovation era. The speakers also discussed ways to formulate effective IP strategies for companies to stand out from the crowd in a competitive business environment. The second plenary session, "The Future is Open: Managing and Commercialising IP Assets" was addressed by Roger Martin, Senior Vice President and Chief IP Strategist, Qualcomm Incorporated; Kenneth S Korea, Senior Vice President and Head of US IP Center, Samsung Electronics Co. Ltd; and Dr Udo Meyer, Senior Vice President and Head of Global Intellectual Property, BASF SE. The three industry experts offered insights on ways to facilitate product development through open innovation while maintaining competitiveness and market share. The opening day also offered breakout sessions covering four main areas: IP Practical Tips, IP Market Insight, Industry-specific IP and Quick Guide to IP Basics. Meanwhile, the two-day IP Manager Training Programme, co-organised by the HKTDC and the Intellectual Property Department of the HKSAR Government, helps provide basic IP training for SMEs to raise their competitiveness. IP, innovation and technology converge at Global Tech Summit Technological innovation is closely linked to IP. The inaugural Global Tech Summit invited representatives from research institutes and technology enterprises, including Hanson Robotics, cherrypicks, DJI, Siemens, Vitargent and VeriFi (Hong Kong) to share their thoughts on the relationship between IP and technological innovation. The speakers explored global technology trends, shared success cases of breakthrough technologies and examined the relationship between technological innovation and IP. China's 13th Five-Year Plan under the spotlight Tomorrow's plenary session entitled "Looking into China's 13th Five-Year Plan: New Opportunities in the Innovation Era", welcomes Yang Guoxin, Deputy Division Director, Planning and Statistics Division of Planning and Development Department, State Intellectual Property Office of the People's Republic of China; Wang Yueping, Deputy Managing Director, Energy Service Division, CGN CLP Energy Services (Shenzhen) Co., Ltd.; and Danny Ng, Senior Vice President, Sales & Marketing, Altai Technologies Limited. They will give expert analysis on the opportunities and effects arising from China's blueprint for development over the next five years. Breakout sessions explore hot topics Tomorrow's breakout sessions will investigate hot IP issues for different sectors. Topics include "Social Media Law and IP Issues Relating to 3D Printing", "Partnering with Universities and Research Institutions in the Era of Open Innovation", "Resolution of IP Disputes - Recent Developments", "Strategic IP Management in China's Film and Creative Industries", "Fashion and IP: New Materials and Technology Applications", "IP Financing: Global Success Models and the Roadmap for Hong Kong", "Brexit and IP: Impacts and Implications", and "Start-ups and IP Business Opportunities". New strategic partners for Asia IP Exchange The Asia IP Exchange (AsiaIPEX) lists more than 27,000 tradable IP items ranging from patents, trademarks and copyrights to registered designs, covering such industries as biotechnology, medicine, electronics and engineering, film and publication. It is the largest platform of its kind in Asia. During the BIP Asia Forum the HKTDC will sign memoranda of understanding with three new strategic partners - British Columbia Institute of Technology, Okinawa Invention and Innovation Institute and The Association of Corporate Patent Executives - to strengthen information exchange and cooperation in IP, expanding the number of strategic partners for the AsiaIPEX to 35. In addition, the HKTDC will sign another memorandum of understanding with the Chongqing Intellectual Property Office to strengthen information exchange and cooperation in IP, so as to facilitate IP trading for enterprises capitalising on the rapidly growing IP market in the Chinese mainland. The BIP Asia exhibition is being staged alongside the main forum to provide more business opportunities for forum participants. It features more than 90 exhibitors, including the World Intellectual Property Organization, major international technology companies, leading local and overseas R&D centres, universities and IP services providers, including Marks & Clerk, Deacons and China Patent Agent. The exhibition provides one-stop on-site advisory services, ranging from knowledge transfer and commercialisation to the application, authorisation and trading of such IP as patents, trademarks and copyrights, as well as relevant laws. Websites Business of Intellectual Property Asia Forum: http://bipasiaforum.com/en/index.htm Asia IP Exchange: http://www.asiaipex.com/Home/Index_EN Photo Download Link: http://bit.ly/2gIxfIy Media Registration: Media may register on-site with their business cards and/or media identification. To view press releases in Chinese, please visit http://mediaroom.hktdc.com/tc About HKTDC Established in 1966, the Hong Kong Trade Development Council (HKTDC) is a statutory body dedicated to creating opportunities for Hong Kong's businesses. With more than 40 offices globally, including 13 on the Chinese mainland, the HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. With 50 years of experience, the HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing information via trade publications, research reports and digital channels including the media room. For more information, please visit: www.hktdc.com/aboutus. Follow us on Google+, Twitter @hktdc, LinkedIn. Google+: https://plus.google.com/+hktdc Twitter: http://www.twitter.com/hktdc LinkedIn: http://www.linkedin.com/company/hong-kong-trade-development-council Contact:
News Article | December 14, 2016
BEIJING, Dec. 14, 2016 /PRNewswire/ -- Recon Technology, Ltd. (NASDAQ: RCON), ("Recon" or the "Company"), a leading independent oilfield services provider operating primarily in China, today announced the recent completion of contracts entered into in November 2016 with PetroChina Changqing Oilfield Company ("PCOC"), China's largest oil producer and subsidiary of PetroChina ("CNPC"), (NYSE: PTR). The total value of these completed contracts was more than RMB 5 million and will be recorded as revenue in fiscal 2017. Recon was chosen in a highly competitive bidding process based on a combination of its expertise, price, and past successes. This is also a significant headway since the Company was qualified as Class A furnace supplier for PetroChina in December 2015 (for further information, please refer to December 14, 2015, "Recon Technology, Ltd. Subsidiary Qualifies as Class A Furnace Supplier for PetroChina and Inks RMB 3.22 Million (US$0.5 million) Contract"). The Company began working in the Changqing oilfield in March 2016, and to date the Company has completed furnace sale contracts totaling RMB15.88 million. The Changqing oil field ("Changqing"), located in the Erdos basin, is China's biggest crude and gas producer with total proven oil and gas reserves over 4500 million tons. Changqing is also the biggest gas and oil contributor to PetroChina, covering Shaanxi, Gansu, Ningxia, Inner Mongolia and Shanxi provinces, and plays the pivotal role of supplying oil and natural gas to cities including Beijing, Tianjin and Shijiazhuang. Changqing Oilfield has seen continuous growth of oil and gas production and rapid development since 2000. The Company provided PCOC with energy-efficient heating furnaces for crude oil transportation. Recon has leveraged the Company's continued investment in R&D to produce considerable cost-savings for oil producers by further offering an advanced, reliable, automated, safe and highly heat-efficient solution. Recon currently owns or has applied for 38 patents registered with the State Intellectual Property Office, which cover its automated products and heating related equipment for the petroleum industry. Mr. Shenping Yin, Chairman and CEO of Recon stated, "These furnace contracts have reinvigorated our business and positioned us well with a significant new customer. As oil prices reach current stable level, demands of our oilfield clients will also continuously increase. With our technical advantages and reliable reputation in the oil industry, Recon is taking advantage of the promising Changqing oilfield. This immense market represents an opportunity for growth at Recon due to oil producers seeking to gain efficiencies downstream. We believe that our customers can benefit from the investments made in researching methods to reduce costs in all facets of the oil processing cycle, which could present strong opportunities for Recon to provide new services and products in addition to heating furnaces. We also believe that Recon has earned our clients' trust to present more complex and integrated solutions that allow them to achieve their goals of lean production management. We are pleased to have completed this recent set of contracts and look forward to moving into calendar 2017." Recon Technology, Ltd. is China's first listed non-state owned oil and gas field service company on NASDAQ. Recon supplies China's largest oil exploration companies, Sinopec (NYSE: SNP) and CNPC, with advanced automated technologies, efficient gathering and transportation equipment and reservoir stimulation measure for increasing petroleum extraction levels, reducing impurities and lowering production costs. Through the years, RCON has taken leading positions on several segmented markets of the oil and gas filed service industry. RCON also has developed stable long-term cooperation relationship with its major clients, and its products and service are also well accepted by clients. For additional information please visit us at www.recon.cn. This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/recon-technology-announces-completion-of-additional-contracts-with-petrochina-changqing-oilfield-company-300378089.html
News Article | November 11, 2016
SHENZHEN, China, Nov. 11, 2016 /PRNewswire/ -- The 18th China Hi-Tech Fair (CHTF) 2016 will be held from November 16 to 21, in Shenzhen, Guangdong Province, China. At the fair, there will be opportunities for everyone to be close to the latest and hottest Hi-tech creations! CHTF is a platform to exhibit Hi-tech products and provide communication opportunities for technological companies. Globalization is one of main characteristics of CHTF. Last year there were over 3,600 exhibitors from 90 countries & regions to show about 4,500 Hi-Tech products and projects. This large-scale platform, with the total 150,000sqm of exhibition area and high quality operative services, attracted nearly 4,000 investors' attention and 600,000 visitors. Also in attendance were almost 1,500 journalists and 214 overseas and domestic news outlets. CHTF will be divided into 10 zones Located at the centre of SZCEC, Hall 1 will be IT-related products. International Pavilions and 'Belt & Road' areas are set in Hall 1 as well. Other zones will display: Green Buildings, Aerospace, New Energy and New Electronic Technology & Applications. The Green Buildings show is a new addition in 2016, presenting the leading technology to make the world a better and cleaner place. There will also be 3 new additions: Innovation, Research & Development, Advanced Manufacturing Technology and State Intellectual Property Office. All are welcome to join the fair! 'Innovation-driven, Quality-oriented' is the main theme of CHTF 2016. With 17 years of successful fairs, CHTF is a very famous and significant commercial platform with a global impact on different industries, especially science and technology. According to feedback from exhibitors presenting last year, over 80% of them desire to participate again. This country's leading technology event is visited by many official departments. Every year, CHTF is held at Shenzhen Convention & Exhibition Center (SZCEC), Fuhua Third Road, Futian District, Shenzhen. For more details, visit http://www.chtf.com/english/
News Article | November 7, 2016
HAIFA, Israel, Nov. 07, 2016 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced that the State Intellectual Property Office of the People's Republic of China has issued an allowance to Pluristem for its patent application titled, “Adherent Cells From Adipose or Placenta Tissues and Use Thereof In Therapy”. The patent addresses methods of treating Ischemic conditions such as CLI using placental cells. Additional patents of Pluristem in China cover methods of expending placental cells in a 3D apparatus, various therapeutic uses of placental cells and devices for a 3D culture of placental cells. “This most recent patent strengthens our intellectual property position globally, and specifically in the Chinese market. With our recent announcement of potential strategic partnership with Innovative Medical, we believe that PLX cell therapy products may have an important role in addressing the needs of China’s rapidly growing healthcare market and aging population,” stated Pluristem Chairman and CEO, Zami Aberman. Pluristem Therapeutics Inc. is a leading developer of placenta-based cell therapy products. The Company has reported robust clinical trial data in multiple indications for its patented PLX (PLacental eXpanded) cells. The cell products release a range of therapeutic proteins in response to inflammation, ischemia, hematological disorders, and radiation damage. PLX cell products are grown using the Company's proprietary three-dimensional expansion technology. They are off-the-shelf, requiring no tissue matching prior to administration. Pluristem has a strong intellectual property position; Company-owned and operated, GMP-certified manufacturing and research facilities; strategic relationships with major research institutions; and a seasoned management team. This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, we are using forward-looking statements when we discuss that our products may have an important role in addressing the needs of China’s rapidly growing healthcare market and aging population. These forward-looking statements and their implications are based on the current expectations of the management of Pluristem only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; we may encounter delays or obstacles in launching and/or successfully completing our clinical trials; our products may not be approved by regulatory agencies, our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties may develop with our process; our products may wind up being more expensive than we anticipate; results in the laboratory may not translate to equally good results in real clinical settings; results of preclinical studies may not correlate with the results of human clinical trials; our patents may not be sufficient; our products may harm recipients; changes in legislation; inability to timely develop and introduce new technologies, products and applications; loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of Pluristem to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Pluristem undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting Pluristem, reference is made to Pluristem's reports filed from time to time with the Securities and Exchange Commission.
News Article | November 10, 2016
Unique battery management system for distributed energy storage is now patented in the United States and China TUALATIN, OR--(Marketwired - Nov 9, 2016) - Powin Energy Corporation ( : PWON), a leading designer and developer of safe and scalable energy storage solutions for utilities, C&I, and electric vehicle (EV) fast-charging stations, is announcing today that it has been awarded a Certificate of Invention Patent by the State Intellectual Property Office of the People's Republic of China for its visionary Battery Pack Operating System (bp-OS). This is the second patent for Powin Energy's bp-OS, which was awarded a United States patent in June of this year. "Our patented software is the only battery management system engineered specifically for energy storage system use cases and having our intellectual property protected by two of the largest economies in the world creates tremendous market opportunity," said Virgil Beaston, CTO of Powin Energy. "The bp-OS reduces the amount of DC connectors and other components that are required to transfer energy using BMS software that was designed for EVs. This allows us to connect more batteries onto a single string and potentially reduce the number of transformers, inverters, and electrical work on a project, all of which yields massive savings for Powin Energy customers." The patented bp-OS takes a unique approach to balancing batteries utilized in stationary storage systems. Rather than working to maintain energy equilibrium across an entire array of batteries that transfers energy between packs - like an EV battery management system (BMS) which is also often used for large scale storage systems -- Powin Energy's bp-OS balances individual cells to an optimized level by connecting each battery pack to the network. This industry-first approach minimizes voltage differentials across all battery cells over the system's lifetime and keeps the delta between the highest and lowest charged cells to a max of 10 millivolts. The bp-OS is battery pack technology agnostic and delivers real-time battery monitoring, state-of-charge management, and detailed diagnostics to ensure safety, optimize performance, and extend the operational lifetime of batteries used in stationary storage systems and EV fast-charging systems. Powin Energy's bp-OS also exclusively features a Battery Odometer and Warranty Tracker™. The Battery Odometer measures capacity degradation and calculates remaining battery lifetime by keeping track of voltage, temperature, state-of-charge, charge and discharge times, and other critical data for every cycle of the battery. The Warranty Tracker™ maximizes operational uptime and prevents potential economic losses by alerting operators to possible issues, isolating problem zones, automatically filing warranty claims, and avoiding full-system shutdowns. These two integral features of Powin Energy's bp-OS make lithium-ion batteries safer and more efficient by preventing them from overcharging or undercharging, avoiding costly unplanned outages, and extending battery life by reducing capacity fade. About Powin Energy Corporation Powin Energy ( : PWON) is incorporated in the state of Nevada and is a leading designer and developer of safe and scalable battery energy storage solutions, based on its patented Battery Pack Operating System (bp-OS), for utility, microgrid and EV fast-charging applications. Powin Energy's patented bp-OS helps extend the life of batteries by actively and reactively balancing battery functions down to the cell level. It also provides critical insight into battery system functions and lifespan via its proprietary Battery Odometer and Warranty Tracker™. For more information, visit http://PowinEnergy.com/. Investors can find Real-Time quotes and market information for the company at http://www.otcmarkets.com/stock/PWON/quote.
News Article | October 31, 2016
JERUSALEM--(BUSINESS WIRE)--Intec Pharma Ltd. (NASDAQ:NTEC) (TASE:INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces that the State Intellectual Property Office of the People’s Republic of China (SIPO) has granted a Chinese patent for an Accordion Pill containing certain drugs, including the combination of Carbidopa and Levodopa. The patent, granted under No. ZL 200980120103.9, is titled “Carbidop
News Article | October 28, 2016
BioFactura, Inc. was granted patent rights by China’s State Intellectual Property Office (SIPO) protecting the core technologies of its proprietary StableFastTM Biomanufacturing Platform. SIPO allowed 17 claims broadly covering composition of matter and methods. StableFastTM is BioFactura’s proprietary NS0-based system to rapidly generate stable cell lines that have the potential to lower cost, produce follow-on biologics and are single-use technology compatible. The Company is developing high-value biosimilars both internally and collaboratively. “This new allowance continues BioFactura’s 100% success record with multiple patent grants in the US and internationally for StableFast and significantly expands our market exclusivity for NS0-produced biosimilars in China,” said Darryl Sampey, BioFactura’s President and CEO. Dr. Jeffrey Hausfeld, Chairman and Chief Medical Officer, stated, “The granting of the Chinese patent for BioFactura's StableFast Biomanufacturing Platform further enhances our ability to bring our products to a global market. We are excited about the possibility of providing high-quality, cost-effective biosimilar drugs to patients in China and throughout the Asia.” About BioFactura BioFactura (Frederick MD) develops and commercializes high-value, highly similar biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast™ Biomanufacturing Platform, the optimal system for bringing these drugs to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.